New Head of Care Solutions Business Line in Evonik’s Nutrition & Care division
Effective July 1, 2020 Yann d’Hervé will take over the responsibility as Head of Evonik’s Care Solutions Business Line, part of the Nutrition & Care division.
Yann d’Hervé was appointed to the position after successfully leading the Global Sales & Services department in the Health Care Business Line.
Yann d’Hervé, who holds a MSc in Chemistry and an MBA, joined the former REXIM SAS (France) in 1996. After holding a number of positions in manufacturing in the Fine Chemicals Business Line until 2004, he moved to the USA to join what is today’s Oil Additives Business Line, working as a business analyst and subsequently as Global Business Director for Wax Modifiers. In 2011, the Health Care Business Line was formed and Yann d’Hervé became Vice President, Sales & Services Americas. In 2015, he assumed his current function as Vice President, Global Sales & Services.
Yann brings experience in manufacturing, finance, marketing, application technology and sales and has managed international organizations while being responsible for strategic alliances with key partners. Customer satisfaction and joint value creation are two cornerstones in Yann’s approach to business.
Company information
Evonik is one of the world leaders in specialty chemicals. The company is active in more than 100 countries around the world and generated sales of €13.1 billion and an operating profit (adjusted EBITDA) of €2.15 billion in 2019. Evonik goes far beyond chemistry to create innovative, profitable and sustainable solutions for customers. More than 32,000 employees work together for a common purpose: We want to improve life, today and tomorrow.
Disclaimer
In so far as forecasts or expectations are expressed in this press release or where our statements concern the future, these forecasts, expectations or statements may involve known or unknown risks and uncertainties. Actual results or developments may vary, depending on changes in the operating environment. Neither Evonik Industries AG nor its group companies assume an obligation to update the forecasts, expectations or statements contained in this release.